Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment

Go back to Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
(NASDAQ: DRMA) Delayed: 1.30 --0 (-0%)
Previous Close $1.30    52 Week High
Open $1.30    52 Week Low
Day High $1.30    P/E N/A 
Day Low $1.30    EPS
Volume 21